The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Institutional Ownership: 0.00% (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
21 GF Score
Price BDT320.40
View Full Analysis

What is The IBN SINA Pharmaceutical Industry Institutional Ownership?

The IBN SINA Pharmaceutical Industry DHA:IBNSINA +0.85% 21 Institutional Ownership is 0.00% as of Jul. 28, 2026. GuruFocus rates DHA:IBNSINA with a GF Score™ of 21/100.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, The IBN SINA Pharmaceutical Industry's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, The IBN SINA Pharmaceutical Industry's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, The IBN SINA Pharmaceutical Industry's Float Percentage Of Total Shares Outstanding is N/A.

The IBN SINA Pharmaceutical Industry Institutional Ownership Historical Data

* Premium members only.

The historical data trend for The IBN SINA Pharmaceutical Industry's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry Institutional Ownership Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
Institutional Ownership

The IBN SINA Pharmaceutical Industry Semi-Annual Data
Institutional Ownership
DHA:IBNSINA
21GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.00% mean?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a Institutional Ownership of 0.00% as of Jul. 28, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on The IBN SINA Pharmaceutical Industry and its competitors.
Is The IBN SINA Pharmaceutical Industry's Institutional Ownership too high?
The IBN SINA Pharmaceutical Industry's current Institutional Ownership is 0.00%. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's Institutional Ownership compare to IMNPQ?
The IBN SINA Pharmaceutical Industry's Institutional Ownership of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. The IBN SINA Pharmaceutical Industry's current Institutional Ownership is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current Institutional Ownership of 0.00%. The current Institutional Ownership is 0.00%. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current Institutional Ownership is 0.00% as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
21GF Score

Get the complete analysis for DHA:IBNSINA

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT320.40
Price